AstraZeneca Pharma Q4 net profit at Rs 3.22 crore
New Delhi: Drug firm AstraZeneca Pharma India reported a net profit of Rs 3.22 crore for the quarter ended March 31.
The company had posted a net loss of Rs 9.55 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Revenue from operations of the company stood at Rs 150.72 crore for the quarter under consideration. It was Rs 116.88 crore in the year-ago period.
For the entire fiscal ended March, the company posted a net profit of Rs 25.91 crore. It was Rs 20.05 crore for the same period a year ago.
Revenue from operations of the company for 2017-18 stood at Rs 571.98 crore. It was Rs 548.65 crore in the previous fiscal.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd